Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 11,430 shares at $104.39 ($1.2M) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($1.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.39 | 3,544 | $370K | 30.8% |
| 2 | $105.30 | 5,417 | $570K | 47.4% |
| 3 | $106.18 | 2,469 | $262K | 21.8% |
| Total | $105.21 avg | 11,430 | $1.2M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $721K | — | Filing → |